Literature DB >> 30212788

Parental-reported neurodevelopmental issues in Loeys-Dietz syndrome.

R T Collins1, J M Flor2, X Tang3, J M Bange4, Y A Zarate5.   

Abstract

BACKGROUND: Loeys-Dietz syndrome (LDS) is a congenital multisystem disorder affecting the cardiovascular and musculoskeletal system. Limited data have reported neurodevelopmental (ND) issues in LDS. AIMS: To determine the extent of ND issues in patients with LDS.
METHODS: A prospective study was performed of LDS patients or their caregivers. The study included data collected via an online survey of age-specific questions. Standard statistical methods were used for baseline and demographic characteristics, as well as group comparisons. OUTCOMES: Data were obtained from 67 patients with LDS (54% female). Median age was 14.9 years. Gene mutations included TGFBR1 (39%), TGFBR2 (40%), SMAD3 (7%), and unknown (14%). Motor delays (30%, 18/61) and hypotonia (63%, 37/60) occurred frequently. Physical (62%, 39/62), occupational (41%, 23/56), and speech therapies (34%, 20/58) were common. Feeding issues were common (41%, 23/56). TGFBR1 mutations were more frequent among those with motor delays and feeding issues.
CONCLUSIONS: Patients with LDS and/or their caregivers report at least one ND problem in most cases, and many require therapies. These data suggest ND disorders should be considered to be part of the phenotype.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Feeding; Loeys-Dietz syndrome; Motor delay; Neurodevelopmental; Physical therapy

Mesh:

Substances:

Year:  2018        PMID: 30212788     DOI: 10.1016/j.ridd.2018.08.003

Source DB:  PubMed          Journal:  Res Dev Disabil        ISSN: 0891-4222


  2 in total

Review 1.  Neonatal presentation of Loeys-Dietz syndrome: two case reports and review of the literature.

Authors:  Francesco Baldo; Laura Morra; Agnese Feresin; Flavio Faletra; Yasmin Al Naber; Luigi Memo; Laura Travan
Journal:  Ital J Pediatr       Date:  2022-06-06       Impact factor: 3.288

Review 2.  Clinical and genetic data of 22 new patients with SMAD3 pathogenic variants and review of the literature.

Authors:  Bertrand Chesneau; Thomas Edouard; Yves Dulac; Hélène Colineaux; Maud Langeois; Nadine Hanna; Catherine Boileau; Pauline Arnaud; Nicolas Chassaing; Sophie Julia; Guillaume Jondeau; Aurélie Plancke; Philippe Khau Van Kien; Julie Plaisancié
Journal:  Mol Genet Genomic Med       Date:  2020-03-10       Impact factor: 2.183

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.